Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
08/15/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals' ARX-04 Phase 3 Trial Met its Primary Endpoint, Reduced Pain Intensity in ER Patients with Moderate-to...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/02/20167:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/01/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present Initial Results of Phase 3 Study of ARX‑04 at World Congress of Mountain & Wilderness Med...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/29/20166:13AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/28/20164:10PMPR Newswire (US)AcelRx Pharmaceuticals Provides Corporate Update and Reports Second Quarter and Six Months 2016 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/26/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Thursday, July 28th, 2016NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/08/20166:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
07/06/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present at Cantor Fitzgerald 2nd Annual Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/28/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Completes Patient Enrollment in Remaining Phase 3 Studies of ARX-04 as a Potential Treatment of Modera...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/27/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Joins Russell 3000 and Russell 2000 IndexesNASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/22/20166:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/22/20166:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/22/20166:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/22/20166:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/22/20166:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/22/20164:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/21/20164:33PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/21/20164:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/02/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Participate in Three Upcoming Healthcare Investor Events in JuneNASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/26/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Presents Results from Phase 3 Study of ARX‑04 following Ambulatory Abdominal Surgeries at Euroanaest...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/24/20167:00AMPR Newswire (US)New Study Reveals Cost of Initial IV Opioid Dose in the Emergency Department for the Treatment of Acute Pain Exceeds $140NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/16/20161:04PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/12/20166:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/06/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals Presents Subgroup Analysis Demonstrating Positive Results of ARX‑04 by Type of Abdominal SurgeryNASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/04/20167:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present at Two Upcoming Investor Events in MayNASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/04/20166:18AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/02/20165:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/02/20164:01PMPR Newswire (US)AcelRx Pharmaceuticals Provides Corporate Update and Reports First Quarter 2016 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/28/20165:18PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/28/20165:17PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX